Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'

Published 01/05/2024, 14:09
Updated 01/05/2024, 15:10
© Reuters.  Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'
FCX
-
DAL
-
EW
-
TTD
-
ROKU
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

On CNBC's “Mad Money Lightning Round,” Jim Cramer said the new product line of Edwards Lifesciences Corporation (NYSE:EW) is “pulling back here.” “That may be the right level to buy it. They are doing very well now,” he added.

On April 25, Edwards Lifesciences posted better-than-expected results for its first quarter. The company said it sees FY24 adjusted EPS of $2.70 to $2.80 on revenue of $6.3 billion to $6.6 billion.

When asked about Freeport-McMoRan (NYSE:FCX), he said, “I want it to come in first, it's been straight up. I do not like parabolic moves.”

On April 23, Freeport-McMoRan reported first-quarter FY24 results. Revenue stood at $6.32 billion, beating the consensus of $5.66 billion. Adjusted EPS was 32 cents, beating the consensus of 27 cents.

The “Mad Money” host said he likes Delta Air Lines, Inc. (NYSE:DAL) very much and likes United Airlines Holdings, Inc. (NASDAQ:UAL) too. “I think they're both good. Now, remember, they're very inexpensive stocks, but they trade wildly. But I do like Delta,” he added.

On April 10, Delta Air Lines reported better-than-expected first-quarter earnings. Delta reported a first-quarter 2024 operating revenue growth of 8% year-over-year to $13.748 billion and adjusted operating revenue of $12.563 billion (+6% YoY), beating the consensus of $12.57 billion. Adjusted EPS was 45 cents, above the consensus of 36 cents, according to data from Benzinga Pro.

The Trade Desk, Inc. (NASDAQ:TTD) is doing “fantastically,” Cramer said. “Jeff Green [CEO of The Trade Desk] is doing a remarkable job, and lot of people prefer it to Google. So I will tell you that even though it's a very expensive stock, it is a good stock. And I would not sell it, I'm more inclined to buy it below the 80 level.”

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On April 30, Roku, Inc. (NASDAQ:ROKU) announced plans for a new data-driven TV streaming partnership with Trade Desk to equip advertisers with better planning, buying, and measurement of TV streaming media.

Price Action:

  • Edwards LifeSciences shares fell 1.5% to settle at $84.67 on Tuesday.
  • Delta shares fell 0.8% to close at $50.07 on Tuesday.
  • Freeport-McMoRan shares fell 4.7% to settle at $49.94 on Tuesday.
  • Trade Desk shares fell 2% to settle at $82.85 during Tuesday's session.

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.